HomePLRX • NASDAQ
Pliant Therapeutics Inc
add
$1.38
0.73%
After Hours:(0.00%)0.00
$1.38
Closed: May 16, 4:02:19 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 58.94M | 12.49% |
Net income | -56.17M | -19.62% |
Net profit margin | — | — |
Earnings per share | -0.92 | -17.95% |
EBITDA | -58.49M | -12.74% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 305.65M | -36.64% |
Total assets | 344.77M | -33.90% |
Total liabilities | 87.61M | 3.96% |
Total equity | 257.16M | — |
Shares outstanding | 61.39M | — |
Price to book | 0.33 | — |
Return on assets | -39.73% | — |
Return on capital | -43.23% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -56.17M | -19.62% |
Cash from operations | -48.86M | -61.42% |
Cash from investing | 69.11M | 16.07% |
Cash from financing | 498.00K | -97.71% |
Net change in cash | 20.75M | -59.37% |
Free cash flow | -32.48M | -78.72% |
Previous close
$1.37
Day range
$1.32 - $1.43
Year range
$1.10 - $16.07
Market cap
84.71M USD
Avg Volume
838.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
171
